Dr. Kenneth Anderson of the Dana-Farber Cancer Institute and Vice President of the American Society for Hematology (ASH) shares about the exciting advances being discussed at the ASH annual conference this weekend in Orlando, Florida.
Advertisement
[the_ad id="32629"]